NCT06334120 2026-03-12An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in KoreaBayerRecruiting600 enrolled
NCT05202301 2025-08-11A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication CompletelyBayerCompleted13,779 enrolled